top of page
Nov 307 min read
PoundsPunch Periodical November 2024: Policy Showdowns, Counterfeit Crises, and Industry Disruptions in the Weight-Loss Drug Market
Biden’s Weight-Loss Drug Proposal Faces Trump-Era Challenges, Ireland’s Crackdown on Counterfeits, and China’s Next-Gen GLP-1 Innovations
Nov 192 min read
Medicare Coverage for Weight Loss Medications Could Cost $35 Billion by 2034, Says CBO
New Proposal to Expand Medicare Coverage Raises Questions on Cost and Potential Savings
Nov 194 min read
FTC Sues Prescription Drug Middlemen for Inflating Insulin Prices—What Does that Mean?
Caremark, Express Scripts, and OptumRx Face Allegations of Rigging the Rebate System
Oct 283 min read
PoundsPunch Periodical October 2024
Medicare’s Lower Drug Premiums, Lilly’s Shortage Supply Resolved While Compounding Pharmacies Still in Play
Sep 264 min read
The US Senate Grills Novo Nordisk on High Prices for Ozempic and Wegovy
A Heated Exchange on the Super Star Weight Loss Drugs' Price, Big Pharma and PBM's Finger-Pointing Game
Sep 234 min read
PoundsPunch Periodical September 2024
Insurers Raise Premiums or Drop Coverage Due to High Costs of Weight Loss Drugs; FDA Approves New Oral Weight Loss Pill Welcome to...
Aug 276 min read
PoundsPunch Periodical August 2024
Commercial Insurance Dominated Weight Loss Prescriptions, Medicare May Target Wegovy for Price Cuts, FDA Reported Eased Drug Shortages
Jul 2914 min read
PoundsPunch Periodical July 2024
House Bill to Expand Medicare Weight Loss Drug Coverage, The Novo Nordisk CEO to Testify in Senate, Lilly’s Approval in China and More
Jun 57 min read
PoundsPunch Periodical June 2024
Weight Loss Drug & Erectile Dysfunction, Eli Lilly’s New Factory, Weight Regain after Stop Using the Drug
bottom of page